WA
CLB icon

Winfield Associates’s Core Laboratories CLB Stock Holding History

Winfield Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5
Closed -$1K – 216
2017
Q4 		$1K Hold
5
– – ﹤0.01% 741
2017
Q3 		$0 Sell
5
-5
-50% -$485 ﹤0.01% 803
2017
Q2 		$1K Hold
10
– – ﹤0.01% 761
2017
Q1 		$1K Hold
10
– – ﹤0.01% 649
2016
Q4 		$1K Hold
10
– – ﹤0.01% 612
2016
Q3 		$1K Hold
10
– – ﹤0.01% 596
2016
Q2 		$1K Hold
10
– – ﹤0.01% 591
2016
Q1 		$1K Buy
+10
New +$1.04K ﹤0.01% 562

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Winfield Associates's CLB Position: Q1 2018 in Review

Winfield Associates sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 5 shares — an estimated $1K sold.

Winfield Associates first reported a position in CLB in Q1 2016 and held it in 8 quarters. The position peaked at $1K in Q4 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Winfield Associates reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 5 Core Laboratories shares in Q1 2018, an estimated $1K.
  • Winfield Associates first reported a position in Core Laboratories in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Core Laboratories position peaked at $1K in Q4 2017.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.